Eloquest Healthcare and Vancive Medical Technologies to Introduce New Post-Operative Dressings with CHG Antimicrobial
March 30 2017 - 1:17PM
Business Wire
Eloquest Healthcare ReliaTect Post-Op
dressings will be introduced at the AORN Global Surgical Conference
& Expo in Boston, MA
A line of transparent post-operative dressings designed to
enhance patient care will be jointly introduced by Eloquest
Healthcare®, Inc. and Vancive Medical Technologies™, an Avery
Dennison (NYSE:AVY) business at AORN in Boston, MA. The device just
received 510(k) clearance from the FDA.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20170330006009/en/
The new dressings, called ReliaTect™, incorporate BeneHold™ CHG,
an innovative adhesive technology from Vancive Medical
Technologies, that comfortably secures the dressing to the skin,
absorbs fluids and protects the site from external contaminants.
The CHG contained within the adhesive preserves the dressings from
microbial growth, making them ideally suited for post-operative
sites. Eloquest Healthcare is the exclusive distributor of the
dressings in the United States and Canada.
“The unique characteristics of the ReliaTect post-operative
dressings make them a great complement to our growing portfolio and
increases the value we are able to provide to our customers,” said
Tim O’Halla, President and CEO for Eloquest Healthcare. “The
BeneHold CHG adhesive technology delivers the combination of fluid
management and sustained transparency with antimicrobial effect of
chlorhexidine gluconate, offering clinicians a simple and
innovative solution for post-op site management.”
The ReliaTect dressings will be available in two sizes (small
and large) and designed to be ideal for various post-operative
sites.
“BeneHold CHG adhesive technology adds value to post-operative
dressings,” said Kirsten Newquist, general manager for Vancive
Medical Technologies. “The collaboration with Eloquest Healthcare
brings together complementary resources, experience and expertise
from each company. We look forward to working with Eloquest
Healthcare to bring ReliaTect to market.”
Eloquest Healthcare and Vancive Medical Technologies will
showcase the new Eloquest Healthcare ReliaTect dressings in booth
#3019 at the AORN Global Surgical Conference & Expo, April 2—4
in Boston, MA. To learn more about the Eloquest Healthcare
ReliaTect post-operative dressings with CHG, visit
http://www2.eloquesthealthcare.com/ReliaTectLaunch.
About Eloquest Healthcare
Eloquest Healthcare, Inc. is a wholly owned subsidiary of
Ferndale Pharma Group, Inc. that is focused specifically on serving
hospitals, their healthcare practitioners, and patients. Eloquest
Healthcare helps deliver safer, more compassionate care by
providing intuitive, cost-effective solutions that complement
treatment protocols. More information can be found at
www.eloquesthealthcare.com.
About Vancive Medical Technologies
Vancive Medical Technologies is a medical technology company
with more than three decades of expertise in adhesive chemistries
and material technologies for medical applications using pressure
sensitive adhesives. The company's applications and technologies
are an integral part of products that are in daily use in medical
facilities throughout the world. Through long-term relationships
with original equipment manufacturers, industry-specific converters
and leading universities, Vancive Medical Technologies continually
finds new ways to develop products that can improve patient care.
Vancive Medical Technologies is an Avery Dennison business
headquartered in Chicago, Illinois. To learn more about Vancive
Medical Technologies, visit www.vancive.averydennison.com.
About Avery Dennison
Avery Dennison (NYSE:AVY) is a global leader in
pressure-sensitive and functional materials and labeling solutions
for the retail apparel market. The company’s applications and
technologies are an integral part of products used in every major
industry. With operations in more than 50 countries and more than
25,000 employees worldwide, Avery Dennison serves customers in the
consumer packaging, graphical display, logistics, apparel,
industrial and healthcare industries. Headquartered in Glendale,
California, the company reported sales of $6.1 billion in 2016.
Learn more at www.averydennison.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170330006009/en/
Eloquest Healthcare Contacts:Matthew StahlClinical Marketing
& Brand
Director248.586.8428mstahl@eloquesthealthcare.comorVancive
Contacts:Andrew DeckertGlobal Marketing Communications Manager+1
224 374 2109andrew.deckert@averydennison.comorBarbara Van
RymenamGlobal Director, CHG Program+32 (0)497
103233barbara.van.rymenam@eu.averydennison.com
Avery Dennison (NYSE:AVY)
Historical Stock Chart
From Jul 2024 to Aug 2024
Avery Dennison (NYSE:AVY)
Historical Stock Chart
From Aug 2023 to Aug 2024